Clinical Trial Update: Evaluation of the Vasoconstriction Properties of MC2-01 Cream [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the vasoconstriction properties of MC2-01 Cream has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasoconstriction

Drugs mentioned

• MC2-01 Cream

Snippet

Sponsor: MC2 Therapeutics | Conditions: Vasoconstriction | Phase 1 | Status: COMPLETED | Results posted: 2020-01-09